You are here

Article info

Article menu
Download PDFPDF
Respiratory research
Original article
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction

Authors

  • Rachele Pandolfi Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Bianca Barreira Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Enrique Moreno Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Victor Lara-Acedo Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Daniel Morales-Cano Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Andrea Martínez-Ramas Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Beatriz de Olaiz Navarro Department of Thoracic Surgery, Hospital Universitario de Getafe, Getafe, Spain PubMed articlesGoogle scholar articles
  • Raquel Herrero Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Critical Care, Hospital Universitario de Getafe, Madrid, Spain PubMed articlesGoogle scholar articles
  • José Ángel Lorente Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Critical Care, Hospital Universitario de Getafe, Madrid, Spain Universidad Europea, Madrid, Spain PubMed articlesGoogle scholar articles
  • Ángel Cogolludo Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Francisco Pérez-Vizcaíno Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Laura Moreno Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain Gregorio Marañón Biomedical Research Institution (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Laura Moreno, Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain; lmorenog{at}med.ucm.es
View Full Text

Citation

Pandolfi R, Barreira B, Moreno E, et al
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction
Thorax 2017;72:460-471.

Publication history

  • Received November 17, 2015
  • Revised June 23, 2016
  • Accepted July 7, 2016
  • First published July 27, 2016.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/